Business · 1 sources covering this

Sun Pharma To Commercialise Novel Bad Cholesterol Drug Lerodalcibep In Ex-US, China Markets

Sun Pharma will commercialise and manufacture lerodalcibep in global markets outside the US and China after securing exclusive rights from LIB Therapeutics.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·1h ago
Sun Pharma To Commercialise Novel Bad Cholesterol Drug Lerodalcibep In Ex-US, China Markets
Sun Pharma will commercialise and manufacture lerodalcibep in global markets outside the US and China after securing exclusive rights from LIB Therapeutics.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/f5f41ee7a9c2f38787d304fffb24d093113a820a"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Sun Pharma To Commercialise Novel Bad Cholesterol Drug Lerodalcibep In Ex-US, China Markets"></iframe>

Sun Pharma To Commercialise Novel Bad Cholesterol Drug Lerodalcibep In Ex-US, China Markets

How 1 sources are covering this

Sun Pharma To Commercialise Novel Bad Cholesterol Drug Lerodalcibep In Ex-US, China Markets

More from Business

Nvidia $150 billion buyback: Why Jensen Huang is betting on AI growth

MTV VMAs 2026 Winners List: Taylor Swift, BTS Shine; Madonna Takes Top Honours

Who is Parvesh Verma? Delhi PWD minister involved in Tilak Nagar road inspection slap controversy

Asiad 2026: Yashvir wins silver, Rohit claims bronze in men's javelin final

Reader

Trust & legal

Across the network